The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Pickering, Pamela
    Individual (2 offsprings)
    Officer
    2007-06-19 ~ now
    OF - Secretary → CIF 0
  • 2
    Appelbee, Stephen Charles
    Company Director born in February 1956
    Individual (8 offsprings)
    Officer
    2007-06-19 ~ now
    OF - Director → CIF 0
    Mr Stephen Charles Appelbee
    Born in February 1956
    Individual (8 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

YORK HOUSE PHARMA LIMITED

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Fixed Assets - Investments
197,907 GBP2024-06-30
162,794 GBP2023-06-30
Debtors
207,834 GBP2024-06-30
196,686 GBP2023-06-30
Cash at bank and in hand
16,151 GBP2024-06-30
74,297 GBP2023-06-30
Current Assets
223,985 GBP2024-06-30
270,983 GBP2023-06-30
Creditors
Current, Amounts falling due within one year
-8,608 GBP2024-06-30
-6,244 GBP2023-06-30
Net Current Assets/Liabilities
215,377 GBP2024-06-30
264,739 GBP2023-06-30
Total Assets Less Current Liabilities
413,284 GBP2024-06-30
427,533 GBP2023-06-30
Equity
Called up share capital
100 GBP2024-06-30
100 GBP2023-06-30
Retained earnings (accumulated losses)
413,184 GBP2024-06-30
427,433 GBP2023-06-30
Equity
413,284 GBP2024-06-30
427,533 GBP2023-06-30
Average Number of Employees
12023-07-01 ~ 2024-06-30
12022-07-01 ~ 2023-06-30
Property, Plant & Equipment - Gross Cost
Other
1,636 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
1,636 GBP2023-06-30
Property, Plant & Equipment
Other
0 GBP2024-06-30
0 GBP2023-06-30
Other Debtors
Amounts falling due within one year
207,834 GBP2024-06-30
196,686 GBP2023-06-30
Trade Creditors/Trade Payables
Current
432 GBP2024-06-30
0 GBP2023-06-30
Corporation Tax Payable
Current
1,349 GBP2024-06-30
1,251 GBP2023-06-30
Other Creditors
Current
6,827 GBP2024-06-30
4,993 GBP2023-06-30
Creditors
Current
8,608 GBP2024-06-30
6,244 GBP2023-06-30

  • YORK HOUSE PHARMA LIMITED
    Info
    Registered number 06285339
    166 College Road, Harrow HA1 1RA
    Private Limited Company incorporated on 2007-06-19 (18 years). The company status is Active.
    The last date of confirmation statement was made at 2024-06-19
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.